phase-3
(2)Company
Company
Health
Orbus Bet $71 Million on One Brain-Cancer Trial - Then the Definition of the Disease Changed
A tiny Palo Alto biotech took an old molecule into a global Phase 3 trial. The broad result failed, but a new molecular map of brain cancer revealed where the drug may actually work - and offered a playbook for anyone building in a market whose definitions move mid-experiment.
orbus-therapeutics · biotechnologyRead →
Health · Hardware · Enterprise
Orca Bio
Orca Bio is a late-stage biotechnology company in Menlo Park, California, building high-precision allogeneic cell therapies. Its proprietary single-cell sorting platform purifies donor immune and stem cells to engineer optimized therapeutic mixtures aimed at curing blood cancers and autoimmune diseases, with its lead candidate Orca-T currently under FDA priority review.
cell-therapy · precision-medicineRead →